Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.
New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial ...
New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...
As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...
In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...
A study using agentic artificial intelligence to detect early signs of cognitive decline in unstructured m | Mass General ...
ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...
Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...
Navigating today’s rapidly evolving clinical trial landscape can be tough. With intricate protocols and shifting regulatory demands, it’s more difficult than ever to find and keep participants, as ...
MedPage Today on MSN
Mystery brain disease in Canada; Alzheimer's clinical trial lawsuit; brains in space
Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback